Monday’s Trending Stocks: CBS, Medivation, HPE, Boeing, Sagent Pharmaceuticals
The benchmark S&P 500 index has jumped six points on Monday, setting a new all-time high as last week’s strong jobs report continues to buoy market sentiment.
Posts Tagged ‘NASDAQ:SGNT’
What’s the Deal With These Surging Stocks Amid Today’s Gloomy Market?
U.S stocks did not spend too much time in green territory today, heading south soon after the opening bell.
A Look at Steve Cohen’s Latest Portfolio Addition & Two Other Hedge Fund Bullish Moves
At Insider Monkey we follow around 730 hedge funds and other institutional investors and ahead of the New Year, several funds from our database have reported some interesting ...
Hedge Funds Are Selling Sagent Pharmaceuticals Inc (SGNT)
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Do Hedge Funds and Insiders Love Akorn, Inc. (AKRX)?
To many of your peers, hedge funds are viewed as useless, old investment tools of an era lost to time.
Hedge Funds Are Betting On Momenta Pharmaceuticals, Inc. (MNTA)
Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.
Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
This Metric Says You Are Smart to Buy Sagent Pharmaceuticals Inc (SGNT)
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age.
Hedge Funds Are Crazy About Ligand Pharmaceuticals Inc. (LGND)
At the moment, there are dozens of methods investors can use to monitor the equity markets. Some of the most useful are hedge fund and insider trading interest.
Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.
Sagent Pharmaceuticals Inc (SGNT): Hedge Funds and Insiders Are Bearish, What Should You Do?
If you'd ask most investors, hedge funds are viewed as unimportant, old financial tools of yesteryear.
Hedge Funds Aren’t Crazy About Hi-Tech Pharmacal Co. (HITK) Anymore
In the 21st century investor’s toolkit, there are tons of indicators shareholders can use to monitor stocks.
Hedge Funds Are Crazy About Momenta Pharmaceuticals, Inc. (MNTA)
In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to track Mr. Market.
Is Hi-Tech Pharmacal Co. (HITK) Going to Burn These Hedge Funds? – Sagent Pharmaceuticals Inc (SGNT), Momenta Pharmaceuticals, Inc. (MNTA)
Hi-Tech Pharmacal Co. (NASDAQ:HITK) was in 11 hedge funds' portfolio at the end of December.
This Week in Biotech: Navidea Biopharmaceuticals Inc (NAVB), Sinovac Biotech Ltd. (SVA) and More
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) up 28% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Has Spectrum Pharmaceuticals, Inc. (SPPI) Become the Perfect Stock? – Sagent Pharmaceuticals Inc (SGNT)
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Down 35%! Spectrum Pharmaceuticals, Inc. (SPPI) Is a Biotech Trainwreck: Sagent Pharmaceuticals Inc (SGNT), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is hurting today after dialing back guidance for the year. Apparently the increased production by Sagent Pharmaceuticals Inc.
Why Bears Are Devouring Spectrum Pharmaceuticals, Inc. (NSPPI)
Just 10 days ago, I examined the bear thesis on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) as, amazingly, over half of its float was sold short.
Spectrum Pharmaceuticals, Inc. (SPPI) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
